Crocs director granted 1,252 shares in stock award
REPLOGLE JOHN B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
REPLOGLE JOHN B reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director John B. Replogle received a stock-based compensation award of 1,252 shares of common stock on June 9, 2026. The shares were granted at no cash cost as the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, and increased his direct holdings to 19,669 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,252 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents the annual common stock grant to non-employee directors pursuant to the issuer's Board of Directors Compensation Plan.
Key Figures
Key Terms
non-employee directors financial
Board of Directors Compensation Plan financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Crocs (CROX) director John B. Replogle report?
Was the Crocs (CROX) director stock grant an open-market purchase?
What is the transaction code used in this Crocs (CROX) Form 4 filing?
How is the Crocs (CROX) non-employee director grant described in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.